Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia

Leukemia and Lymphoma

Volumn 25, Issue 3-4, 1997, Pages 225-232

  Costello, Régis ^a   Sainty, Danielle ^a   Lafage Pochitaloff, Marina ^a   Gabert, Jean ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

aCML; BCR negative; Chronic myeloid leukemia; Disorder; Leukemia; Myeloproliferative; Philadelphia chromosome

Indexed keywords

BCR ABL PROTEIN; HYBRID PROTEIN;

ADULT; CANCER GENETICS; CARCINOGENESIS; CELL STRUCTURE; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; ONSET AGE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

EID: 0030927365     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709114162     Document Type: Review

References (45)

1. [a] Kantarjian, H. M., Kurzrock, R. and Talpaz, M. (1990). Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol. Oncol. Clin. North Am., 4, 389-404.
2. Ezdinli, E. Z., Sokal, J. E. and Crosswhite, L. (1970) Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann. Intern. Med., 72, 175-182
3. Kantarjian, H. M., Shtalrid, M. and Kurzrock, R. (1986). Clinical and prognostic features of Philadelphia chromosome-negative myelogenous leukemia. Cancer, 58, 2023-2030.
4. Pugh, W. C., Pearson, M., Wardiman, J. W. and Rolwey, J. D. (1985). Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br. J. Haematol., 60, 457-461.
5. 1-negative chronic granulocytic leukemia: a nonentity. Am J. Clin. Pathol., 85, 186-191.
6. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1982). The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br J. Haematol., 51, 189-199.
7. Solal-Celigny, P., Desaint, B., Herrera, A., Chastang, C., Amar, M., Vroclans, M., Brousse, N., Mancilla, F., Renoux, M., Bernard, J. F. and Boivin, P. (1984). Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood, 63, 634-638.
8. Greenberg, P. L. and Bagby, G. C. (1982). The preleukaemic syndrome (hemopoietic dysplasia). In S. R. Newcom & M. E. Kadin (Eds.). Hematologic malignancies in the adult (pp. 1-7). Reading, Mass: Addison-Wesley.
9. Freedman, M. H., Cohen, A., Grunberger, T., Bunin, N., Luddy, R. E., Saunders, E. F., Shahidi, N., Lau, A. and Estrov, Z. (1992) Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia Br. J. Haematol., 80, 40-48.
10. Galton, D. A. G. (1992). Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia. Leuk. Lymphoma, 7, 343-350.
11. Martiat, P., Michaux, J. L. and Rodhain, J. (1991). Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique. Blood, 78, 205-211.
12. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H., Sultan, C. and Cox, C. (1994). The chronic myeloid leukaemias' guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Brit. J. Haematol., 87, 746-754.
13. Kurzrock, R., Kantarjian. H. M., Shtalrid, M., Gutterman, J. U. and Talpaz, M. (1990). Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. Blood, 75, 445-452.
14. Costello, R., Lafage, M., Toiron, Y., Brunel, V., Sainty, D., Arnoulet, C., Mozziconacci, M., Bouabdallah, R., Gastaut, J., Maraninchi, D. and Gabert, J. (1995). Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases Brit. J. Haematol., 90, 346-352.
15. Groupe Français de Cytogénétique Hématologique. (1991). Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet. Cytogenet., 55, 57-65.
16. Groupe Français de Cytogénétique Hématologique. (1986). Cytogenetics of chrome myelomonocytic leukemia. Cancer Genet. Cytogenet., 21, 11-17
17. Oscier, D. G. (1996). Atypical chronic myeloid leukemia, a distinct clinical entity related to the myelodysplastic syndrome? Brit. J. Haematol., 92, 582-586
18. Zhang, J., Meltzer, P., Jenkins, R., Guan, X. Y. and Trent, J. (1993). Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood, 81, 3365-3371.
19. 1) translocation in chronic myelogenous leukemia. Leukemia, 2(10), 648-657.
20. Bentz, M., Cabot, G., Moos, M., Speicher, M., Ganser, A., Lichter, P. and Döhner, H. (1994) Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood, 83, 1922-1928.
21. Kuwao, F. and Takahashi, I. (1993). Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method. Leukemia, 7, 1168-1173.
22. Chen, Z., Morgan, R., Berger, C. S., Pearce Birge, L., Stone, J. F. and Sandberg, A. A. (1993). Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes. Cancer Genet. Cytogenet., 70, 103-107.
23. Seong, D. C., Liu, P., Siciliano, J., Zhao, Y., Cork, A., Henske, E., Warburton, D., Yu, M. T., Champlin, R., Trujillo, J. M. and et al (1993) Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization. Cancer Genet. Cytogenet., 65, 100-103.
24. Amiel, A., Yarkoni, S., Fejgin, M., Gaber, E., Nagler, A., Manor, Y. and Lishner, M. (1993). Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia. Cancer Genet. Cytogenet., 65, 32-34.
25. Bartram, C. R. (1985). bcr rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia. J. Exp. Med., 162, 2175-2179.
26. Sawyers, C. L. and Denny, C. T. (1994). Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell, 77, 171-173.
27. Golub, T. R., Barker, G. F., Lovett, M. and Gilliland, D. G. (1994). Fusion of PDGF receptor b to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation. Cell, 77, 307-316.
28. Ganesan, T. S., Rassool, F., Guo, A. P., Th'ng, K. H., Dowding, C., Hibbin, J. A., Young, B. D., White, H., Kumaran, T. O., Dalton, D. A. G. and Goldman, J. M. (1986). Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myelogenous leukemia. Blood, 68, 987-960.
29. Morris, C. M., Reeve, A. E., Fitzgerald, P. H., Hollings, P. E., Beard, M. E. J. and Heaton, D. C. (1986). Genomic diversity correlates with clinical variation in Ph-negative chronic myeloid leukaemia. Nature, 320, 281-283.
30. Bartram, C. R. and Carbonell, F. (1986). bcr rearrangement in Ph-negative CML. Cancer Genet. Cytogenet., 21, 183-184.
31. Fitzgerald, P. H., Beard, M. E. J., Morris, C. M., Heaton, D. C. and Reeve, A. E. (1987). Ph-negative chronic myeloid leukemia. Brit. J. Haematol., 66, 311-314.
32. Dreazan, O., Rassool, F., Sparkes, R. S., Klisak, I., Goldman, J. M. and Gale, R. P. (1987). Do oncogenes determine clinical features in chronic myeloid leukemia? Lancer, i, 1402-1405.
33. Wiedemann, L. M., Karhi, K. K., Shivji, M. K. K., Rayter, S. I., Pegram, S. M., Dowden, G., Bevan, D., Will, A., Galton, D. A. G. and Chan, L. C. (1988). The correlation of breakpoint cluster region rearrangement an p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood, 71, 349-355.
34. Bartram, C. R. (1988). Rearrangement of c-abl and bcr genes in Ph-negative CML and Ph-positive acute leukemias. Leukemia, 2, 63-64.
35. Ohyashiki, J. H., Ohyashiki, K., Ito, H. and Toyama, K. (1988). Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer Genet. Cytogenet., 33, 119-126.
36. Kantarjian, H. M., Shtalrid, M., Kurzrock, R., Blick, M., Dalton, W. T., LeMaistre, A., Strass, S. A., McCredie, K. B., Gutterman, J., Freiretch, E. J. and Talpaz, M. (1988). Significance and correlation of molecular-analysis results in patients with Philadelphia chromosome-negative myelogenous leukemia and chronic myelomonocytic leukemia. Am. J. Med., 85, 639-644.
37. Murase, T., Nagai, H., Wakita, A., Fujiwara, Y., Nakaide, Y., Tanaka, M., Ohkita, T. and Hotta, T. (1989). [So-called Ph1-negative chronic myelogenous leukemia with a mosaic pattern of trisomy 8 and normal karyotypes-report of 2 cases]. Rinsho Ketsueki, 30, 509-513.
38. van der Plas, D. C., Grosveld, G. and Hagemeijer, A. (1991). Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet., 52, 143-156.
39. van der Plas, D. C., Hermans, A. B. C., Soerkarman, D., Smit, E. M. E., de Klein, A., Smadja, N., Alimena, G., Goudsmit, R., Grosveld, G. and Hagemeijer, A. (1989). Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 73, 1038-1044.
40. Selleri, L., Emilia, G., Luppi, M., Temperani, P., Zucchini, P., Tagliafico, E., Artusi, T., Sarti, M., Donelli, A., Castoldi, G. L. and et al. (1990). Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative". Hematol. Pathol., 4, 67-77
41. Dobrovic, A., Morley, A. A., Seshadri, R. and Januszewicz, E. H. (1991). Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML. Leukemia, 5, 187-190.
42. Xue, Y. Q. (1993). [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation]. Chung Hua I Hsueh Tsa Chih, 73, 209-12, 252.
43. Hehlmann, R., Queisser, W. P., Essers, U. and Falge, C. (1993). The German CML study, comparison of busulfan vs hydroxyurea vs interferon alpha and establishment of pronostic factors. Leuk. Lymphoma, 11(1), 159-168.
44. Cortes, J., Kantarjian, H., O'Brien, S., Robertson, L., Kurzrock, R., Rios, M. and Talpaz, M. (1993). Philadelphia chromosome (Ph) negative chronic myelogenous leukemia (CML) with rearrangement of the breakpoint cluster region (Bcr-positive). Update of 23 patients. Blood, 82(suppl. 1), 379(abstract).
45. Hoang-Ngoc, L., Brizard, A., Valensi, F., Hermine, O. and Flandrin, G. (1996). Leucémie myéloïde chronique atypique: nouvelle entité individualisée au sein des myélodysplasies. Hematol. Cell Therapy, 38(1), 136(abstract).